Recombination-Independent Genome Editing through CRISPR/Cas9-Enhanced TargeTron Delivery
- 16 August 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 8 (9) , 2186-2193
Abstract
Group II introns were developed some time ago as tools for the construction of knockout mutants in a wide range of organisms, ranging from Gram-positive and Gram-negative bacteria to human cells. Utilizing these introns is advantageous because they are independent of the host’s DNA recombination machinery, they can carry heterologous sequences (and thus be used as vehicles for gene delivery), and they can be easily retargeted for subsequent insertions of additional genes at the user’s will. Alas, the use of this platform has been limited, as insertion efficiencies greatly change depending on the target sites and cannot be predicted a priori. Moreover, the ability of introns to perform their own splicing and integration is compromised when they carry foreign sequences. To overcome these limitations, we merged the group II intron-based TargeTron system with CRISPR/Cas9 counterselection. To this end, we first engineered a new group-II intron by replacing the retrotransposition-activated selectable marker (RAM) with ura3 and retargeting it to a new site in the lacZ gene of E. coli. Then, we showed that directing CRISPR/Cas9 toward the wild-type sequences dramatically increased the chances of finding clones that integrated the retrointron into the target lacZ sequence. The CRISPR-Cas9 counterselection strategy presented herein thus overcomes a major limitation that has prevented the use of group II introns as devices for gene delivery and genome editing at large in a recombination-independent fashion.Keywords
Funding Information
- European Regional Development Fund (S2017/BMD-3691)
- Ministerio de Ciencia e Innovaci?n (RTI 2018-095584-B-C42)
- H2020 Future and Emerging Technologies (H2020-FET-OPEN-RIA-2017-1-766975)
- Consejer?a de Educaci?n, Juventud y Deporte, Comunidad de Madrid (S2017/BMD-3691)
- Ministerio de Educaci?n, Cultura y Deporte (FPU15/04315)
- Horizon 2020 Framework Programme (H2020-NMBP-BIO-CSA-2018)
- FP7 Ideas: European Research Council (322797)
This publication has 34 references indexed in Scilit:
- Group II Introns: Mobile Ribozymes that Invade DNACold Spring Harbor Perspectives in Biology, 2010
- The ClosTron: A universal gene knock-out system for the genus ClostridiumJournal of Microbiological Methods, 2007
- Mobile Group II IntronsAnnual Review of Genetics, 2004
- Use of Computer-designed Group II Introns to Disrupt Escherichia coli DExH/D-box Protein and DNA Helicase GenesJournal of Molecular Biology, 2004
- Group II introns as controllable gene targeting vectors for genetic manipulation of bacteriaNature Biotechnology, 2001
- A bacterial group II intron encoding reverse transcriptase, maturase, and DNA endonuclease activities: biochemical demonstration of maturase activity and insertion of new genetic information within the intronGenes & Development, 1997
- Homing of a group II intron from Lactococcus lactis subsp. lactis ML3Journal of Bacteriology, 1997
- A group II intron RNA is a catalytic component of a DNA endonuclease involved in intron mobilityCell, 1995
- STRUCTURE AND ACTIVITIES OF GROUP II INTRONSAnnual Review of Biochemistry, 1995
- An mRNA maturase is encoded by the first intron of the mitochondrial gene for the subunit I of cytochrome oxidase in S. cerevisiaeCell, 1983